• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Temperament Traits as Key Modulators of Depression and Anxiety in Hyperthyroidism: Implications for Personalized Treatment.气质特质作为甲状腺功能亢进症中抑郁和焦虑的关键调节因素:对个性化治疗的启示
Cureus. 2025 Mar 31;17(3):e81503. doi: 10.7759/cureus.81503. eCollection 2025 Mar.
2
The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample.情感气质和精神病理特征对双相障碍亚型定义的影响:对意大利全国双相 I 样本的研究。
J Affect Disord. 2012 Jan;136(1-2):e41-e49. doi: 10.1016/j.jad.2009.12.027. Epub 2010 Feb 2.
3
TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire.TEMPS-A:孟菲斯、比萨、巴黎和圣地亚哥自填式问卷气质评估临床自评版本的验证进展。
J Affect Disord. 2005 Mar;85(1-2):3-16. doi: 10.1016/j.jad.2004.12.001.
4
Affective temperaments in anorexia nervosa: The relevance of depressive and anxious traits.神经性厌食症的情感气质:抑郁和焦虑特征的相关性。
J Affect Disord. 2017 Aug 15;218:23-29. doi: 10.1016/j.jad.2017.04.054. Epub 2017 Apr 24.
5
Validation of the Brazilian brief version of the temperament auto-questionnaire TEMPS-A: the brief TEMPS-Rio de Janeiro.验证 TEMPS-A 气质自动问卷的巴西简版:里约热内卢简版 TEMPS。
J Affect Disord. 2011 Nov;134(1-3):65-76. doi: 10.1016/j.jad.2011.02.005. Epub 2011 Jul 22.
6
TEMPS-A (Rome): psychometric validation of affective temperaments in clinically well subjects in mid- and south Italy.TEMPS-A(罗马):意大利中南部临床健康受试者情感气质的心理测量学验证
J Affect Disord. 2008 Apr;107(1-3):63-75. doi: 10.1016/j.jad.2007.07.031. Epub 2007 Sep 19.
7
Korean Validation of the Short Version of the TEMPS-A (Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire) in Patients with Mood Disorders.心境障碍患者中 TEMPS-A(孟菲斯、比萨、巴黎和圣地亚哥自动问卷的短版特质情绪测试)的韩文版验证。
Medicina (Kaunas). 2023 Jan 6;59(1):115. doi: 10.3390/medicina59010115.
8
TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament.TEMPS-A:一种旨在测量气质变化的自评工具简版的验证。
J Affect Disord. 2005 Mar;85(1-2):45-52. doi: 10.1016/j.jad.2003.10.012.
9
[Affective temperaments: psychometric properties of the Hungarian TEMPS-A].[情感气质:匈牙利版TEMPS-A的心理测量特性]
Psychiatr Hung. 2006;21(2):147-60.
10
A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders.对情绪障碍患者、其一级亲属、健康对照者及其他精神障碍患者的TEMPS评分进行的比较荟萃分析。
J Affect Disord. 2016 May 15;196:32-46. doi: 10.1016/j.jad.2016.02.013. Epub 2016 Feb 12.

引用本文的文献

1
Exploring the relationship between temperament traits, psychological symptoms, and functional disability assessed with the WHODAS 2.0 in persons with multiple sclerosis.探索多发性硬化症患者的气质特征、心理症状与使用世界卫生组织残疾评定量表2.0评估的功能残疾之间的关系。
Front Neurol. 2025 Aug 12;16:1561995. doi: 10.3389/fneur.2025.1561995. eCollection 2025.

本文引用的文献

1
The Association between Depression, Anxiety, and Thyroid Disease: A UK Biobank Prospective Cohort Study.抑郁、焦虑与甲状腺疾病之间的关联:一项英国生物银行前瞻性队列研究。
Depress Anxiety. 2024 Jul 4;2024:8000359. doi: 10.1155/2024/8000359. eCollection 2024.
2
Psychiatric complications in Graves' disease.格雷夫斯病的精神并发症。
Eur Thyroid J. 2024 Feb 1;13(1). doi: 10.1530/ETJ-23-0247.
3
Psycho-Cognitive Profile and NGF and BDNF Levels in Tears and Serum: A Pilot Study in Patients with Graves' Disease.泪液和血清中的心理认知特征与 NGF 和 BDNF 水平:格雷夫斯病患者的初步研究。
Int J Mol Sci. 2023 Apr 29;24(9):8074. doi: 10.3390/ijms24098074.
4
Graves' disease as a driver of depression: a mechanistic insight.格雷夫斯病(Graves' disease)导致抑郁症的机制研究进展
Front Endocrinol (Lausanne). 2023 Apr 20;14:1162445. doi: 10.3389/fendo.2023.1162445. eCollection 2023.
5
Neuropsychiatric Manifestations of Thyroid Diseases.甲状腺疾病的神经精神表现
Cureus. 2023 Jan 20;15(1):e33987. doi: 10.7759/cureus.33987. eCollection 2023 Jan.
6
Hyperthyroidism and clinical depression: a systematic review and meta-analysis.甲状腺功能亢进和临床抑郁症:系统评价和荟萃分析。
Transl Psychiatry. 2022 Sep 5;12(1):362. doi: 10.1038/s41398-022-02121-7.
7
Reversible Affective Symptoms and Attention Executive Control Network Impairment Following Thyroid Function Normalization in Hyperthyroidism.甲状腺功能亢进症甲状腺功能正常化后可逆性情感症状及注意执行控制网络损害
Neuropsychiatr Dis Treat. 2019 Nov 26;15:3305-3312. doi: 10.2147/NDT.S227386. eCollection 2019.
8
Graves' disease and mental disorders.格雷夫斯病与精神障碍
J Clin Transl Endocrinol. 2019 Oct 11;19:100207. doi: 10.1016/j.jcte.2019.100207. eCollection 2020 Mar.
9
Hyperthyroidism: Diagnosis and Treatment.甲状腺功能亢进症:诊断与治疗
Am Fam Physician. 2016 Mar 1;93(5):363-70.
10
Anxiety and depression are more prevalent in patients with graves' disease than in patients with nodular goitre.Graves 病患者比结节性甲状腺肿患者更易出现焦虑和抑郁。
Eur Thyroid J. 2014 Sep;3(3):173-8. doi: 10.1159/000365211. Epub 2014 Sep 2.

气质特质作为甲状腺功能亢进症中抑郁和焦虑的关键调节因素:对个性化治疗的启示

Temperament Traits as Key Modulators of Depression and Anxiety in Hyperthyroidism: Implications for Personalized Treatment.

作者信息

Alci Deniz, Eroglu Mustafa, Asik Mehmet

机构信息

Psychiatry, Balıkesir University, School of Medicine, Balıkesir, TUR.

Endocrinology, Diabetes, and Metabolism, Balıkesir University, School of Medicine, Balıkesir, TUR.

出版信息

Cureus. 2025 Mar 31;17(3):e81503. doi: 10.7759/cureus.81503. eCollection 2025 Mar.

DOI:10.7759/cureus.81503
PMID:40308388
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12042719/
Abstract

Introduction The relationship between thyroid hormone dysfunction and psychiatric symptoms is complex, with hyperthyroidism frequently presenting alongside mood and anxiety disorders. Temperament traits, enduring psychological characteristics, may significantly influence the clinical manifestation of depression and anxiety in hyperthyroid patients, yet they remain understudied. This study aimed to determine whether specific temperament traits in hyperthyroid individuals correlate with anxiety and depressive symptoms and explore their implications for personalized clinical management. Methods A total of 59 patients diagnosed with hyperthyroidism and 40 healthy controls participated in this study. All participants underwent clinical assessment, thyroid function testing (thyroid-stimulating hormone (TSH), T3, T4), and completed the Hospital Anxiety and Depression Scale (HADS) and the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego Autoquestionnaire (TEMPS-A). Demographic and clinical parameters, including age, gender, body mass index (BMI), blood pressure, smoking status, and family history, were also documented. Statistical analyses included Mann-Whitney U tests for group comparisons, Spearman's correlation analysis for relationships between temperament traits and psychiatric symptoms, and generalized linear models (GLM) to identify predictors of depressive symptoms. Results Hyperthyroid patients exhibited significantly higher anxiety scores compared to controls (p<0.001), whereas depressive symptoms, although elevated, did not reach statistical significance (p>0.05). Temperament assessment revealed significantly increased depressive, cyclothymic, irritable, and anxious traits in patients compared to controls (p<0.001). Hyperthymic temperament showed no significant difference between groups. A notable positive correlation emerged between irritable temperament and increased depressive symptoms (r=0.635, p<0.001). Depressive temperament significantly predicted higher depression scores, while hyperthymic temperament appeared protective, associated with reduced depressive symptoms (p<0.05). Conclusions These findings highlight the importance of temperament traits as critical modulators of psychiatric outcomes in hyperthyroidism. Irritable and depressive temperaments may increase vulnerability to depressive disorders, whereas hyperthymic temperament could offer resilience. Integrating temperament assessment into clinical practice may enhance diagnostic precision and inform personalized therapeutic approaches, improving patient outcomes and quality of life.

摘要

引言 甲状腺激素功能障碍与精神症状之间的关系较为复杂,甲状腺功能亢进症常与情绪和焦虑症同时出现。气质特质,即持久的心理特征,可能会显著影响甲状腺功能亢进症患者抑郁和焦虑的临床表现,但这方面的研究仍较少。本研究旨在确定甲状腺功能亢进症患者的特定气质特质是否与焦虑和抑郁症状相关,并探讨其对个性化临床管理的意义。方法 共有59例诊断为甲状腺功能亢进症的患者和40名健康对照者参与了本研究。所有参与者均接受了临床评估、甲状腺功能测试(促甲状腺激素(TSH)、T3、T4),并完成了医院焦虑抑郁量表(HADS)和孟菲斯、比萨、巴黎和圣地亚哥气质自评问卷(TEMPS-A)。还记录了人口统计学和临床参数,包括年龄、性别、体重指数(BMI)、血压、吸烟状况和家族史。统计分析包括用于组间比较的曼-惠特尼U检验、用于气质特质与精神症状之间关系的斯皮尔曼相关分析,以及用于识别抑郁症状预测因素的广义线性模型(GLM)。结果 与对照组相比,甲状腺功能亢进症患者的焦虑得分显著更高(p<0.001),而抑郁症状虽然有所升高,但未达到统计学显著性(p>0.05)。气质评估显示,与对照组相比,患者的抑郁、环性心境、易怒和焦虑特质显著增加(p<0.001)。两组之间的轻躁狂气质没有显著差异。易怒气质与抑郁症状增加之间存在显著正相关(r=0.635,p<0.001)。抑郁气质显著预测更高的抑郁得分,而轻躁狂气质似乎具有保护作用,与抑郁症状减轻相关(p<0.05)。结论 这些发现凸显了气质特质作为甲状腺功能亢进症精神结局关键调节因素的重要性。易怒和抑郁气质可能会增加患抑郁症的易感性,而轻躁狂气质可能提供恢复力。将气质评估纳入临床实践可能会提高诊断准确性,并为个性化治疗方法提供依据,从而改善患者结局和生活质量。